Gateway enzyme for chemicals from catnip to cancer drugNovember 26, 2012
They are produced naturally by some plants such as the medicinal Madagascar periwinkle, but faster-growing plants could be used to produce them. With synthetic biology, improvements could also be made to them.
The study, to be published in Nature on Thursday, was led by scientists from the John Innes Centre, an institute on Norwich Research Park strategically funded by BBSRC.
"Thousands of chemicals are derived from the enzyme we have called iridoid synthase," says senior author Dr Sarah O'Connor from the JIC and the University of East Anglia.
"We can start to use it to come up with new-to-nature structures with biological activity of benefit to both medicine and agriculture."
Many aphids, often important agricultural pests, produce sex pheromone chemicals that are identical to or that closely resemble the iridoid synthase product. Strategic use of these iridoid chemicals could be used to disrupt the aphids' breeding cycle or to repel them from crops.
The anticancer ingredient vinblastine sulphate is currently derived from the Madagascar periwinkle plant. The iridoid synthase is an essential step in the production of this compound. But vinblastine is produced in just very low levels and the drug has many side effects. The hope is to find a way to produce it more cheaply, easily and with a chemical structure that lessens side effects.
"We need to identify more enzymes to see the entire pathway used in nature to make this potent compound," said Dr O'Connor.
"But the enzyme we have discovered is also the basic scaffold for many other iridoid chemicals and we can start to experiment with building new chemical structures with biological activity."
The backbone of all iridoids consists of two fused rings and scientists have been trying to track down what makes this ring system. Experiments showed that iridoid synthase is the enzyme responsible.
Scientists already knew the enzyme preceeding iridoid synthase and how the gene encoding it is expressed. The lead author, Dr Fernando Geu-Flores from JIC, therefore looked for enzymes that are encoded by genes expressed in a similar way and narrowed down their search to 20 enzymes.
Research published in the 1980s indicated that the missing enzyme is dependent on a particular compound called NADPH, which narrowed the search down to two enzymes.
O'Connor and her co-workers will also investigate whether the enzyme is important in a simple chemical reaction used by chemists for nearly 100 years. Scientists are trying to identify which enzymes catalyse a reaction called the Diels-Alder reaction, named after the Nobel prize-winning scientists who discovered it. A better understanding of how the iridoid synthase works could open up new ways to make pharmaceutical compounds using synthetic biology.
Norwich BioScience Institutes
Related Enzyme Current Events and Enzyme News Articles
Flu viruses disguised as waste
Viral infections always follow a similar course. The pathogen infiltrates the host cells and uses their replication and protein production machinery to multiply.
New insight on why people with Down syndrome invariably develop Alzheimer's disease
A new study by researchers at Sanford-Burnham Medical Research Institute reveals the process that leads to changes in the brains of individuals with Down syndrome-the same changes that cause dementia in Alzheimer's patients.
Precise and programmable biological circuits
A team led by ETH Professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.
Cornell chemists show ALS is a protein aggregation disease
Using a technique that illuminates subtle changes in individual proteins, chemistry researchers at Cornell University have uncovered new insight into the underlying causes of Amyotrophic Lateral Sclerosis (ALS).
Experimental breast cancer drug holds promise in combination therapy for Ewing sarcoma
Ewing sarcoma tumors disappeared and did not return in more than 70 percent of mice treated with combination therapy that included drugs from a family of experimental agents developed to fight breast cancer, reported St. Jude Children's Research Hospital scientists.
Fast modeling of cancer mutations
Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, time-consuming process.
New study demonstrates advances in creating treatment for common childhood blood cancer
Researchers at NYU Langone Medical Center conclude new drug in development may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia.
Scientific breakthrough will help design the antibiotics of the future
Scientists have used computer simulations to show how bacteria are able to destroy antibiotics - a breakthrough which will help develop drugs which can effectively tackle infections in the future.
Viagra protects the heart beyond the bedroom
Viagra could be used as a safe treatment for heart disease, finds new research published today in the open access journal BMC Medicine.
Sharks that hide in coral reefs may be safe from acidifying oceans
A study published online today in the journal Conservation Physiology has shown that the epaulette shark (Hemiscyllium ocellatum) displays physiological tolerance to elevated carbon dioxide (CO2) in its environment after being exposed to CO2 levels equivalent to those that are predicted for their natural habitats in the near future.
More Enzyme Current Events and Enzyme News Articles